Operator
Good afternoon. Thank you for joining us today to discuss OptimizeRx Corporation s first quarter ended March 31, 2021. Speaking on the call today is OptimizeRx s chief executive officer, William Febbo; and the company s chief financial officer, Doug Baker. Miriam Paramore, the company s chief strategy officer; and chief commercial officer, Stephen Silvestro will be present for the Q&A.
Following the remarks, they will open the call for questions. Before we conclude today s call, I ll provide some important cautions regarding the forward-looking statements made by management during today s call. I d like to remind everyone that today s call is being recorded and will be made available for replay via webcast only, and instructions and today s press release are in the investor section of the company s website. Now, I turn the call over to OptimizeRx CEO, Will Febbo.
Operator
Good afternoon. Thank you for joining us today to discuss OptimizeRx Corporation s fourth-quarter and full year ended December 31, 2020. With us today is the chief executive officer of OptimizeRx, William Febbo; and the company s president and chief strategy officer, Miriam Paramore. They are joined by company chief financial officer, Doug Baker; and chief commercial officer, Stephen Silvestro.
Following their remarks, they will open the call for questions. Before we conclude today s call, I ll provide some important cautions regarding the forward-looking statements made by management during today s call. I d like to remind everyone that today s call is being recorded and will be made available for telephone replay via instructions in today s press release and the Investors section of the company s website. Now I d like to turn the call over to OptimizeRx CEO, Will Febbo.